Abstract
Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell Transplant
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have